Ensitrelvir (S-217622) from BIORBYT LTD.
Search, find, compare suppliers for Ensitrelvir (S-217622) products.
| Edit | |
|---|---|
| Product Name | Ensitrelvir (S-217622) |
| Description | S-217622 is the first oral non-covalent, non-peptidic SARS-CoV-2 3CL protease inhibitor with IC50 of 0.096 µM. S-217622 displays antiviral activity in vitro towards a range of SARS-CoV-2 variants and coronavirus families, favorable drug metabolism and pha. MW: 531.88 |
| Size | 100 mg, 1 g, 250 mg, 10 mM * 1 mL in DMSO |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | CAS: 2647530-73-0 |
| Catalog # | orb1473053 |
| Price | please inquire |
| Order / More Info | Ensitrelvir (S-217622) from BIORBYT LTD. |
| Product Specific References | n/a |
BIORBYT LTD.
BIORBYT LTD.
7 Signet Court
Swann Road
Cambridge, CB5 8LA U.K.
P: +44 (0)1223 859 353
F: +44(0)1223 280 240
info@biorbyt.com
http://www.biorbyt.com
U.S. OFFICE
Biorbyt LLC
1100 Corporate Square Drive
Helix Center, Suite 221
St Louis, MO 63132
Email: info@biorbyt.com
Phone: +1 (415) 906-5211
Fax: +1 (415) 651-8558
Profile of BIORBYT LTD.
Return to Products